Bad Medicine: Psychiatric medicine.
作者信息
Spence Des
机构信息
Maryhill Health Centre, Glasgow.
出版信息
Br J Gen Pract. 2018 Dec;68(677):583. doi: 10.3399/bjgp18X700049.
Abstract
摘要
相似文献
1
Bad Medicine: Psychiatric medicine.不良医学：精神医学。
Br J Gen Pract. 2018 Dec;68(677):583. doi: 10.3399/bjgp18X700049.
2
Trends in the prescribing of stimulant medication for the treatment of attention deficit hyperactivity disorder in children and adolescents in New South Wales.新南威尔士州儿童和青少年注意力缺陷多动障碍治疗中刺激性药物处方的趋势
N S W Public Health Bull. 2002 Jan;13 Suppl 1:1-65. doi: 10.1071/nb02s01.
3
Psychotropic drug use in very young children.幼儿使用精神药物的情况。
JAMA. 2000 Feb 23;283(8):1059-60. doi: 10.1001/jama.283.8.1059.
4
Prescribing for ADHD in primary care.基层医疗中多动症的处方开具
Br J Gen Pract. 2018 Apr;68(669):170-171. doi: 10.3399/bjgp18X695357.
5
Child psychopharmacology: politics versus science.
Aust N Z J Psychiatry. 2013 Oct;47(10):961. doi: 10.1177/0004867413498938. Epub 2013 Jul 25.
6
The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.丹麦对抗注意力缺陷/多动障碍药物的使用：从患者角度的药物使用研究。
Eur J Clin Pharmacol. 2013 Mar;69(3):589-98. doi: 10.1007/s00228-012-1344-0. Epub 2012 Jul 19.
7
Time for some reason in the ADHD debate.在关于注意力缺陷多动障碍的辩论中，是时候考虑某些原因了。
Aust N Z J Psychiatry. 2013 Oct;47(10):958-9. doi: 10.1177/0004867413498272. Epub 2013 Jul 25.
8
Response to Whitely: a caution from the coalface.对怀特利的回应：来自实际工作一线的警示。
Aust N Z J Psychiatry. 2012 May;46(5):404-6. doi: 10.1177/0004867412444108.
9
Politics vs practice: commentary on the ADHD debate.政治与实践：关于注意力缺陷多动障碍辩论的评论
Aust N Z J Psychiatry. 2013 Jan;47(1):89-91. doi: 10.1177/0004867412459811.
10
ADHD debate clouded by preconceptions and undisclosed conflicts of interest.多动症辩论因先入之见和未披露的利益冲突而蒙上阴影。
Aust N Z J Psychiatry. 2013 Oct;47(10):956-8. doi: 10.1177/0004867413498270. Epub 2013 Jul 25.
本文引用的文献
1
A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?一项关于抗抑郁药戒断效应的发生率、严重程度和持续时间的系统评价：指南是否基于证据？
Addict Behav. 2019 Oct;97:111-121. doi: 10.1016/j.addbeh.2018.08.027. Epub 2018 Sep 4.
2
Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression.注意缺陷多动障碍多模式治疗研究随访中的青年成人结局：症状持续、来源差异和身高抑制
J Child Psychol Psychiatry. 2017 Jun;58(6):663-678. doi: 10.1111/jcpp.12684. Epub 2017 Mar 10.
3
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍（ADHD）的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
4
Antidepressants versus placebo for depression in primary care.基层医疗中治疗抑郁症使用抗抑郁药与安慰剂的对比
Cochrane Database Syst Rev. 2009 Jul 8;2009(3):CD007954. doi: 10.1002/14651858.CD007954.
5
Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.初始严重程度与抗抑郁药疗效：对提交给美国食品药品监督管理局的数据进行的荟萃分析。
PLoS Med. 2008 Feb;5(2):e45. doi: 10.1371/journal.pmed.0050045.
Zotero 插件